Engagement of Veterans With Lung Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

October 25, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2032

Conditions
Lung Cancer (NSCLC)Lung AdenocarcinomaLung Cancer, Non-Small CellLung CarcinomaLung Cancer, Small CellLung Adenocarcinoma With Bronchiolo-alveolar Feature
Interventions
BEHAVIORAL

Lay Health Worker (LHW) Planning

Patients randomized to the LHW group will receive usual care provided by their oncology (or primary) clinical team along with an initial 30-minute telephone call with the LHW from Palo Alto, followed by weekly 15-minute phone calls (or as needed) for 6months. These calls are designed to assist with healthcare planning, symptom management, and discussions about care preferences and goals.

OTHER

Usual Care Group

Participants randomized to the usual care group will receive usual care provided by their oncology clinical team. These teams have been trained in symptom assessment, goals-of-care (GoC) discussions, and documentation of such clinical services. As part of usual care, participants may engage in symptom and GoC discussions at any time, initiated by either the patient or the clinician.

Trial Locations (1)

94304

Veterans Affairs Palo Alto Health Care System (VAPAHCS), Palo Alto

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

US Department of Veterans Affairs

FED

lead

Palo Alto Veterans Institute for Research

OTHER